HPV testing means a high-risk HPV DNA test run on cells brushed from the cervix during a pelvic exam. It's a cervical-cancer screening tool, and it isn't part of a general STD panel. There is no FDA-approved HPV test for men, and genital warts are diagnosed by a clinician looking at them rather than by a swab CDC.
of HPV-attributable cancers
| Item | Value |
|---|---|
| Currently infected | ~42 million |
| New infections / yr | ~13 million |
| Clear within 2 years | ~90% |
| Vaccine prevents | >90% — of HPV-attributable cancers |
How HPV is actually tested
The standard HPV test looks for the genetic material (DNA) of high-risk HPV types in cervical cells. During a speculum exam, a clinician brushes a small sample of cells from the cervix, the same sample used for a Pap smear. That sample goes to a lab, which checks specifically for the cancer-linked types like HPV 16 and 18 and a pool of other high-risk types. It does not test for the low-risk types (6 and 11) that cause warts, because those don't lead to cancer.
Two things this test is not. It is not a confirmatory test for genital warts; a positive or negative HPV result doesn't change how warts are managed, so clinicians don't order it to diagnose or treat warts CDC STI Tx. And it is not part of a routine STD panel. When you get tested for chlamydia, gonorrhea, HIV, and syphilis, HPV is not on that list; it's found through cervical screening instead. If you want a broad infection check, see what's actually on the panel before you get tested.
When to test after exposure
There's no fixed window period for HPV the way there is for, say, HIV or chlamydia. The CDC does not name a number of days, because HPV can stay quiet and then produce warts months or even years after you acquired it, and the time of acquisition usually can't be pinned down. That's also why HPV isn't something you test for right after a specific encounter. It's a screening question tied to your age and cervix, with no after-exposure timeline. For infections that do have a clear testing window, see when to test after exposure.
Who should get screened
Screening recommendations are built around cervical cancer prevention, and they're age-specific. The USPSTF gives cervical screening a Grade A recommendation USPSTF 2018:
- Under 21: no screening, even if you've been sexually active, since early HPV almost always clears on its own.
- Ages 21–29: a Pap (cytology) every three years; HPV testing is not recommended on its own in this age group.
- Ages 30–65: a Pap every three years, OR a high-risk HPV test alone every five years, OR co-testing (Pap plus HPV) every five years.
- Over 65: screening can stop if you've had adequate prior normal screening.
Guidance is shifting toward starting at age 25 with a primary HPV test every five years as the preferred approach, rather than a yearly Pap ACS. Most HPV clears within two years, so testing too early or too often catches infections that would have resolved anyway, while primary HPV testing finds more precancer with fewer visits.
Why there's no HPV test for men
HPV testing is not recommended to screen men, adolescents, or women under age 30. There's no FDA-approved test that reliably detects HPV in men, and no screening pathway that's been shown to improve outcomes for them. For men, HPV usually only becomes visible as genital warts, diagnosed on sight, or much less commonly surfaces through a cancer it has caused. So if a man asks for an "HPV test" on a panel, the test he's picturing doesn't exist.
Anal screening — the unsettled part
CDC's 2021 guidance found the data insufficient to recommend routine anal Pap (cytology) screening, even for men who have sex with men or people with HIV. That position predates the 2022 ANCHOR trial, which showed treating high-grade anal lesions reduced anal cancer in people with HIV. Some specialty groups now suggest periodic anal Pap for the highest-risk groups in places where high-resolution anoscopy referral is available, though this is not a blanket CDC recommendation. If you're in a high-risk group, this is a conversation to have with a clinician who knows your history.
Getting tested: the visit, at-home kits, and cost
In a clinic, HPV screening is folded into a pelvic exam. You'll lie back, the clinician inserts a speculum, and brushes cervical cells in a few seconds; the pressure is the same as a Pap, mildly uncomfortable but quick. The HPV and Pap can often run off the same sample, so co-testing rarely means two separate procedures.
Self-collection is expanding: some programs now allow a vaginal swab you collect yourself, in the clinic or at home, that's then tested for high-risk HPV. Availability varies by provider and region, so check what a given service offers before you commit. You can compare testing providers to see who handles cervical or self-collected HPV screening versus a basic STD panel, which are not the same product.
On cost: HPV screening as part of recommended cervical-cancer screening is generally covered as preventive care, which often means little to no out-of-pocket cost under most insurance plans. A general at-home STD kit won't include an HPV test, so don't assume a multi-test panel covers it.
Reading your results
A high-risk HPV result comes back positive or negative, sometimes with the specific type flagged (often whether it's 16 or 18, since those carry the most cancer risk). A negative result usually means you can wait the full screening interval before the next test. A positive result does not mean you have or will get cancer; it means a high-risk type is present, and most of these clear on their own within two years. What happens next depends on the result combination:
| Result | What it means | Typical next step |
|---|---|---|
| HPV negative, Pap normal | No high-risk virus, normal cells | Resume routine screening interval |
| HPV positive, Pap normal | High-risk virus present, cells still look normal | Repeat testing or type-specific follow-up |
| HPV positive (16/18) | Highest-risk types detected | Often referred for closer look (colposcopy) |
| Abnormal Pap cells | Cell changes seen under the microscope | Colposcopy to examine the cervix directly |
The types that cause warts are not the types that cause cancer. A negative HPV screening test tells you nothing about whether you have wart-causing types, and a wart on your skin doesn't mean your cancer-risk types are positive. They're two different problems sharing one virus family name.
If your result is positive
A positive high-risk HPV test is a flag for closer monitoring rather than a diagnosis, and your clinician will guide follow-up based on your age and result. If you instead have visible genital warts (a low-risk-type problem), those are treated separately: a clinic can freeze them or you can apply a prescription cream at home over several weeks, and no single method is clearly best. Treating warts removes the lesion but not the virus, so they can come back. See genital warts treatment for the full options, and genital warts in women for how they present and recur.
When to see a clinician
Book a visit if you're due for cervical screening by age, if you notice new bumps or warts in the genital or anal area, if you have unexplained bleeding between periods or after sex, or if you got a positive HPV result and need a follow-up plan. Don't wait for symptoms to schedule routine screening, because precancer typically causes no symptoms at all.
The HPV vaccine prevents infection but doesn't treat one. Gardasil 9 protects against future infection with nine HPV types but won't clear an infection or warts you already have, and vaccinated people still need cervical screening on schedule ACS. HPV's reach goes well beyond the cervix — learn more about hpv leading to other kinds of cancers, but vaccine does help to reduce cervical cancer.